NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report)’s share price fell 4.1% on Tuesday . The company traded as low as $2.50 and last traded at $2.59. 40,873 shares were traded during trading, an increase of 67% from the average session volume of 24,518 shares. The stock had previously closed at $2.70.
NeurAxis Stock Down 3.9 %
The company has a market cap of $17.38 million, a PE ratio of -1.35 and a beta of 4.20. The company’s fifty day moving average is $2.71 and its 200-day moving average is $2.89.
About NeurAxis
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
Featured Articles
- Five stocks we like better than NeurAxis
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Calculate Options Profits
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
